ETON MT Newswires 3 days ago Eton Pharmaceuticals Acquires US Commercialization Rights to Pierre Fabre's Hemangeol 📈 AI Sentiment Highly Positive 8/10
ETON GlobeNewswire 3 days ago Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution